News

Optimal Research, a patient identification and trial activation service provider, and OncoLens, a software as a service (SaaS) tumor board solution asserted to partner to bring…
Read More...

DanDrit Biotech USA, Inc. asserted the completion of acquisition of Enochian Biopharma. DanDrit possesses a perpetual, fully paid up, royalty free, sublicensable, exclusive, license to…
Read More...

GenePOC asserted the launch of GenePOC GBS LB assay which is implied to be in its home market for the revogene instrument. The revogene is an automated stand-alone instrument that…
Read More...

US-based scientific camera designer and manufacturer Photometrics, scientific instruments manufacturer Cairn Research and systems developer Mizar Imaging have curated a partnership to…
Read More...

PANTHERx Specialty Pharmacy, THE Rare Disease Specialty Pharmacy asserted that it has received the Verified Internet Pharmacy Practice Sites VIPPS accreditation form the National…
Read More...

Anew Era TMS is a provider of transcranial magnetic stimulation TMS for treating individuals with medication-resistant depression and skin disorders. TMS offers and extends a safe and…
Read More...

Athletico Physical Therapy has opened a new location in Dearborn Heights on 19th February. Vowing to extend quality care throughout the Metro Detroit area. Michael Leither, PT, OCS…
Read More...

Non-profit organization, Aeras committed to developing vaccines against TB declared results from breakthrough Clinical Trial aiding evidence that TB Vaccines could forbid sustained…
Read More...

Gel-e declared having sought two new grants that advocate the development of internal use of hemostats. Gel-e has clinched a $1.4M grant from the Department of Defense through the US…
Read More...

The American Veterinary Medical Foundation and the Veterinary Pharmacology Research Foundation have selected two veterinary researchers as receivers of the organizations pharmacology…
Read More...

Cardax asserted that it has forayed into a Purchase Agreement with Health Elite Club limited of Hong Kong for distribution of ZanthoSyn implied for inflammatorry health and longevity in…
Read More...

SenzaGen asserted that the company has signed a global licensing agreement with leading contract research organization Eurofins BioPharma Product Testing Munich to endorse the GARD test…
Read More...

Lonza Pharma and Biotech and Denali Therapeutics asserted having entered into a strategic partnership on Denali's biologic pipeline products for neurodegenerative diseases.The agreement…
Read More...

Roche and Flatiron Health asserted that the two partners have ventured into a definitive agreement enumerating that Roche will acquire all shares of Flatiron  Health from an existing…
Read More...

AbbVie asserted results from the double-blinded extension phase of the Phase 2 CELEST Study, exhibiting that many patients treated with upadacitinib who attained clinical response after…
Read More...

Great Point Partners, LLC submitted a letter to the Board of Directors of BioCryst Pharmaceuticals strongly rebuking BCRX's merger with Idera Pharmaceuticals. The letter states "We…
Read More...

Novartis declared additional results from the SCULPTURE study marking that two thirds of moderate to severe plaque psoriasis patients treated with Cosentyx exhibited zero impact of skin…
Read More...

 Photocure ASA asserted that the U.S Food and Drug Administration approved its supplemental new drug application to extend the indication for Blue Light Cystoscopy with Cysview to…
Read More...

Teva Pharmaceutical Industries asserted the commercial availability of QVAR RediHaler Inhalation Aerosol to patients in both 40 mcg and 80 mcg strengths by prescription in the U.S QVAR…
Read More...

GT Biopharma focused on the development and commercialization of novel cancer immunotherapy products as well as central nervous system treatments asserted the appointment of Shawn M.…
Read More...